Relationship of serum immunoglobulines and IgG subclasses in previously healthy adult patients with community acquired pneumonia Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009
Early high antibody titre convalescent plasma for hospitalised COVID-19 patients: DAWn-plasma Source: Eur Respir J, 59 (2) 2101724; 10.1183/13993003.01724-2021 Year: 2022
Very high levels of serum immunoglobulin E (IgE): A clinical profile of 18 children Source: Annual Congress 2010 - Paediatric asthma, rhinitis and management Year: 2010
Serum level of specific IgG antibody for aspergillus and its association with severity of asthma in asthmatic children Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Levels of immunoglobulins of classes A and G in saliva in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 586s Year: 2005
Late Breaking Abstract - The respiratory tract of patients with antibody deficiency on immunoglobulin replacement is characterised by inflammation and dysbiosis despite adequate levels of sputum IgG Source: Virtual Congress 2021 – Bronchiectasis heterogeneity: assessing the endotypes Year: 2021
Serum immunoglobulin E (IgE) in COPD: analysis of the German COSYCONET cohort Source: International Congress 2019 – COPD treatment: clinical trials, cohorts and inhaler device studies Year: 2019
High prevalence of serum IgA antibodies against gliadin in patients with interstitial lung diseases confirmed by immunoblotting Source: Eur Respir J 2003; 22: Suppl. 45, 227s Year: 2003
Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients Source: Eur Respir J, 56 (2) 2001526; 10.1183/13993003.01526-2020 Year: 2020
Increased relative levels of IgG subclasses, mainly IgG3, in patient with bronchiectasis and history of exacerbations; preliminary results from a single tertiary center. Source: International Congress 2019 – Clinical aspects of airway diseases Year: 2019
Respiratory disease in a cohort of patients with primary antibody deficiency Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma Year: 2019
SIT follow-up: Measurements of specific IgG and IgG4 serum levels Source: Eur Respir J 2002; 20: Suppl. 38, 507s Year: 2002
Altered IgG but normal IgA responses to pneumococcal proteins in lung fluid and serum in HIV infected adults Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010
Study to determine reference ranges for specific serum IgG against antigens implicated in hypersensitivity pneumonitis in Singapore Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017
Convalescent Plasma does not improve in-hospital mortality among low SARS-CoV-2-IgG antibodies in COVID-19 hospitalized patients Source: Virtual Congress 2021 – COVID - 19 treatments Year: 2021
Change of T2-markers in patients with severe uncontrolled asthma treated by monoclonal antibodies: 1 yr follow up Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021
Measurement of serum total antioxidant status in patients with community acquired pneumonia: correlation with the severity of the disease Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002
DNA methylation and serum total immunoglobulin E (IgE) levels: a methylome-wide association study in adults with asthma Source: International Congress 2018 – Role of omics in population studies Year: 2018
Correlation between total serum immunoglobulin E and allergen specific immunoglobulin E in children with allergic disease Source: Annual Congress 2009 - New developments in preschool wheezing disorders and its genetic basis Year: 2009
Pulmonary immunoglobulin E levels and the response to anti-immunoglobulin E antibody therapy in paediatric severe therapy resistant asthma Source: Annual Congress 2012 - Treating childhood asthma Year: 2012